Polyclonal proliferation of plasma cells associated with marked hypergammaglobulinemia in an elderly patient

International Journal of Hematology

Volumn 81, Issue 1, 2005, Pages 62-65

  Ohno, Hitoshi ^a   Tanaka, Hideaki ^a   Sakai, Hisashi ^a   Katsurada, Tatsuya ^a   Yoshida, Yataro ^a  

^a TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

CD30; Flow cytometry; Immunoelectrophoresis; Polyclonal hypergammaglobulinemia; Polyclonal plasmacytosis

Indexed keywords

ALPHA1 INTEGRIN; CD19 ANTIGEN; CD20 ANTIBODY; CD30 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; M PROTEIN; SYNDECAN 1;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOPHENOTYPING; LYMPHADENOPATHY; MYELOMA CELL; PLASMA CELL; PLASMA CELL LEUKEMIA; PLASMACYTOSIS; POLYCLONAL ACTIVATION; SPLENOMEGALY;

AGED; AGED, 80 AND OVER; CELL DIVISION; FATAL OUTCOME; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; PLASMA CELLS;

EID: 12844264059     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04136     Document Type: Article

References (11)

1. Gawoski JM, Ooi WW. Dengue fever mimicking plasma cell leukemia. Arch Pathol Lab Med. 2003;127:1026-1027.
2. Jego G, Robillard N, Puthier D, et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood. 1999;94:701-712.
3. Shtalrid M, Shvidel L, Vorst E. Polyclonal reactive peripheral blood plasmacytosis mimicking plasma cell leukemia in a patient with staphylococcal sepsis. Leuk Lymphoma. 2003;44:379-380.
4. Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc. 2001;76:476-487.
5. Jaffe ES, Ralfkiaer E. Angioimmunoblastic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:225-226.
6. Sallah S, Gagnon GA. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haematol. 1998;99:57-64.
7. Greiner T, Armitage JO, Gross TG. Atypical lymphoproliferative diseases. Hematology (Am Soc Hematol Educ Program). 2000:133-146.
8. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989;74:1360-1367.
9. + anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000;96:3681-3695.
10. de Bruin PC, Gruss HJ, van der Valk P, Willemze R, Meijer CJ. CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia. 1995;9:1620-1627.
11. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood. 1994;83:2045-2056.